Phio Pharmaceuticals Corp. Share Price & Technical Analysis
PHIO · $1.09 (0.00%)
Healthcare / Biotechnology
$1.09
0.00%
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene exp…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
-8% return in May, 4% avg return in past 3 year May month.
11% return in 2026, -88% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 10% | 9% | 0% | -8% | – | – | – | – | – | – | – | 11% |
| 25 | 17% | -30% | -7% | 46% | 0% | 15% | 0% | -17% | 25% | -17% | -63% | -17% | -47% |
| 24 | -20% | 80% | -37% | 3% | 5% | -6% | -47% | -16% | 25% | -12% | -10% | -38% | -72% |
| 23 | 30% | -12% | 6% | -41% | 7% | -19% | -8% | -19% | -30% | -18% | -11% | -29% | -144% |
| 22 | -15% | -7% | 9% | -7% | -13% | -1% | 1% | 0% | -17% | -3% | -28% | -9% | -90% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$12.66M
P/E ratio
—
52W high
$4.19
52W low
$0.81
Volume
1,15,851
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Phio Pharmaceuticals Corp. share price today?
- Phio Pharmaceuticals Corp. (PHIO) last traded around $1.09 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PHIO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PHIO. Download the app for real-time alerts.
- How can I analyze Phio Pharmaceuticals Corp. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.